FDA official logo
GSRS logo
PFDA official logo

LORVOTUZUMAB MERTANSINE

  • UNII: 0IVD6ASY0W
  • Preferred Substance Name: LORVOTUZUMAB MERTANSINE

  • 1008106-64-6
  • BB-10901
  • HUN901-DM1
  • HUN-901DM1
  • HUN-901-DM1
  • IMGN901
  • IMGN-901
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN CD56 ANTIGEN) (HUMAN-MOUSE MONOCLONAL HUN901 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HUN901 LIGHT CHAIN, DIMER, TETRAAMIDE WITH N2'-(3-((3-CARBOXY-1-METHYLPROPYL)DITHIO)-1-OXOPROPYL)-N2'-DEACETYLMAYTANSINE
  • LORVOTUZUMAB MERTANSINE [INN]
  • LORVOTUZUMAB MERTANSINE [USAN]
  • LORVOTUZUMAB MERTANSINE [WHO-DD]
  • MAYTANSINOID DM1-CONJUGATED HUMANIZED MONOCLONAL ANTIBODY N901

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.